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osting by EAbstract Three rapid, selective and sensitive spectrophotometric methods have been proposed for
the quantitative determination of levocetirizine dihydrochloride (LCT) in pure form as well as in its
pharmaceutical formulation. The methods are based on the charge transfer complexation reaction
of LCT as n-electron donor with 2,4-dinitrophenol (DNP), picric acid (PA) as p-acceptors and
iodine (I2) as r-acceptor to give highly colored radical anion species. The colored products were
quantiﬁed spectrophotometrically at 420 nm with both DNP (method A) and PA (method B)
and at 375 nm with I2 (method C). Under the optimized experimental conditions, Beer’s law is
obeyed over the concentration ranges of 1.2–24, 1.6–32 and 2.4–48 lg mL1 LCZ for method A,
method B and method C, respectively. The values of molar absorptivity, Sandell sensitivity, limits
of detection and quantiﬁcation are also reported. The effect of reaction medium, reaction time and
reagent concentration on the sensitivity and stability of the complexes formed has been examined.
The proposed methods were successfully applied to the determination of LCT in pure form and
commercial tablets and in syrup with good accuracy and precision. Statistical comparison of the
results was performed using Student’s t-test and F-ratio at 95% conﬁdence level and the results
showed no signiﬁcant difference between the reference and proposed methods with regard to accu-
racy and precision. Further to the accuracy and reliability the methods were conﬁrmed by recovery
studies via the standard addition technique.
ª 2012 University of Bahrain. Production and hosting by Elsevier B.V. All rights reserved.821 2419659; fax: +91 821
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lsevier1. Introduction
Levocetirizine dihydrochloride (LCT), (2-[4-[(R)-(4-chloro-
phenyl) phenylmethyl]-1-piperazinyl]ethoxy]-acetic acid dihy-
drochloride) (Fig. 1) is a third generation non sedative
antihistamine (O’Neil andMerck, 2001), and is the active enan-
tiomer of cetirizine dihydrochloride. In many cases, the two
racemic enantiomers differ in their pharmacokinetic and phar-
macodynamic properties. Replacing existing recemates with sin-
gle isomers has resulted in improved safety and/or efﬁcacy
proﬁle of various recemates (Patil and Kothekar, 2006; Bernard
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Figure 1 Structure of LCT.
34 M.S. Raghu, K. Basavaiahet al., 1990). LCT has the advantages of higher efﬁcacy, less side
effects, and longer duration over other antihistamines, and has
begun to replace cetirizine in clinical therapy stepwise. It has
been chemically proved that the half dosage form of LCTZ
(2.5 mg) has comparable antihistaminic activity to normal
amount (5.0 mg) of cetirizine in the treatment of allergic rhinitis
and chronic idiopathic urticaria (Devalia et al., 2001).
Ofﬁcial method (Indian Pharmacopoeia, 2007) describes
acid–base titration with 0.1 M NaOH in acetone/water med-
ium. Literature survey revealed that LCT has been determined
in human serum by reverse-phase high performance liquid
chromatography (RP-HPLC) along with other H1-receptor
antagonists (Saeed arayne et al., 2010) and in plasma by liquid
chromatography-tandem mass spectrometry (Gunasakaran
et al., 2010). Xiangping et al. (2009) have recently reported a
study on the interaction of LCT with human serum albumin
by molecular spectroscopy.
Determination of small amounts of LCT in pharmaceutical
preparations is important for medical and pharmaceutical
needs, and hence it is crucial to develop simple, sensitive, selec-
tive, and cost-effective methods for its determination as a part
of compliance of speciﬁcations study: specimen quantity, sam-
ple homogenity, and content uniformity in tablets.
LCT in combination with a number of other drugs in tablet
dosage form has been assayed by UV-spectrophotometry
(Lakshmana Prabhu et al., 2008; Merukar et al., 2009), ratio
derivative spectrophotometry (Choudhari et al., 2010), TLC-
densitometry (Smita et al., 2010) RP-HPLC (Ashokkumar
et al., 2009; Ambadas and Vaishali, 2010; Kamarapu et al.,
2010; Shaikh and Patil, 2010). However, there are only three re-
ports dealingwith the determination of LCTwhen present alone
in its dosage forms. Li et al. (2000) have reported an UV-spec-
trophotometric method to determine the effective content of
LCT in its tablets. The drug and related substance in solid oral
formulationwere assayed byHPLC (YadavBirendra and Sumit
Yadav, 2010). The same technique has been applied for the sta-
bility-indicatingmethod for the drug in bulk form and in dosage
forms (Dhaneshwar et al., 2006) and for the determination of
LCT conﬁguration stability in tablets using the chiral mode
(Raghad Hommoss and Hind elzein, 2011).
However, many of the reported methods for LCT in single-
dosage form, particularly, the chromatographic methods are
complex, requiring expensive instrumental set up and skilled
operator which are not always found in laboratories of devel-
oping and under developed countries. Thus, the need for a sim-
ple, selective and low-cost method is obvious, especially for
routine quality control analysis of pharmaceuticals containing
LCT. Hence, the authors have made an attempt in this direc-
tion and succeeded in developing three visible spectrophoto-
metric methods based on charge transfer complex formation
reaction involving two p-acceptors (dinitrophenol and picric
acid) and a r-acceptor (iodine).Nitrophenol derivatives such as 2,4-dinitrophenol (DNP),
picric acid (PA) are excellent p-acceptors (El-Yazbi et al.,
2003; Abdel-Hay et al., 2004), and iodine (I2), a r-acceptor
(Gamal, 1998; Azza et al., 2002) and have been widely used
in the assay of several drugs. This paper, for ﬁrst time, de-
scribes the application of these three reagents for the rapid,
selective and sensitive spectrophotometric assay of LCT in
bulk drug and in its dosage forms. The methods involve the
charge-transfer (C-T) complex formation reaction of the drug
with DNP (method A), PA (method B) and I2 (method C) in
dichloromethane to form intensely colored radical anions mea-
surable at 420 nm in methods A and method B and at 375 nm
in method C. The proposed methods are determined to be sim-
ple and rapid employing low cost reagents and instruments.2. Experimental
2.1. Apparatus
All absorption measurements were made using a Systronics
model 106 digital spectrophotometer (Systronics Ltd., Ahme-
dabad, India) with 1 cm path length matched quartz cells.
2.2. Chemicals and reagents
Pharmaceutical grade LCT (certiﬁed to be 99.85% pure) was
procured from Jubiliant Life Sciences Limited, Mysore, India,
and used as received. Allercet 5 mg (Micro labs Ltd.) and Xy-
zal 5 mg (UCB India Pvt. Ltd.) tablets and Lezyncet syrup
(Mepro pharmaceuticals Pvt. Ltd.) were purchased from the
local market and dichloromethane (spectroscopic grade) was
purchased from Merck, Mumbai, India. Distilled water was
used wherever required.
2.2.1. Dinitrophenol (0.05%)
Prepared by dissolving 0.05 g of dinitrophenol (S.D. Fine
Chem Ltd., Mumbai, India) in 100 mL of dichloromethane
and used for the assay in method A.
2.2.2. Picric acid (0.1%)
Prepared by dissolving 0.1 g of picric acid (S.D. Fine Chem
Ltd., Mumbai, India) in 100 mL of dichloromethane and used
for the assay in method B.
2.2.3. Iodine solution (0.5%)
Prepared by dissolving 0.5 g of the pure resublimed iodine
(S.D. Fine Chem Ltd., Mumbai, India) in 100 mL of dichloro-
methane and used after 30 min for the assay in method C.
2.2.4. Sodium hydroxide (1.0 M)
Accurately weighed 1 g of the pure NaOH (Merck, India) was
dissolved in water; the solution was made up to 100 mL with
water.
2.2.5. Standard drug solution (LCZ)
A 300 lg mL1 solution of levocetirizine base was prepared by
dissolving accurately weighed 35.7 mg of the pure LCT in
water and the volume was brought to 100 mL with water in
a calibrated ﬂask and mixed well.
Optimized and validated spectrophotometric methods 352.3. General procedures
2.3.1. Preparation of LCT base (LCZ) solution
Transferred accurately 20 mL of the pure LCZ solution
(300 lg mL1) into a 125 mL separating funnel containing
5.0 mL of 1.0 M NaOH and the content was mixed well. The
levocetirizine base was extracted with three 20 mL portions
of dichloromethane, the extract was passed over anhydrous so-
dium sulphate and collected in a 100 mL volumetric ﬂask, the
volume was made up to mark with dichloromethane and the
resulting solution (60 lg mL1 LCZ) was used for the assay
in method C and diluted to 30 and 40 lg mL1 LCZ for meth-
od A and method B, respectively.
2.4. Construction of calibration curves
2.4.1. Method A (using DNP)
Different aliquots (0.2, 0.5. . .. . .. . .4.0 mL) of standard LCZ
solution (30 lg mL1) were accurately transferred into a series
of 5 mL calibration ﬂasks using a micro burette. One milliliter
of 0.05% DNP solution was added to each ﬂask and diluted
to volume with dichloromethane. The content was mixed well
and the absorbance was measured at 420 nm against a reagent
blank.
2.4.2. Method B (using PA)
Aliquots (0.2, 0.5. . .. . ...4.0 mL) of a standard LCZ (40 lg mL
1) solution were accurately transferred into a series of 5 mL
calibration ﬂasks. To each ﬂask, 1 mL of 0.1% PA solution
was added and the solution was made up to volume with
dichloromethane. The content was mixed well and the absor-
bance was measured at 420 nm against a reagent blank.
2.4.3. Method C (using I2)
Varying aliquots of standard LCZ solution equivalent to 2.4–
48 lg mL1 (0.2–4.0 mL of 60 lg mL1) were accurately mea-
sured and transferred into a series of 5 mL calibrated ﬂasks
and 1 mL of 0.5% iodine solution was added to each ﬂask,
the content was mixed well and the ﬂasks were allowed to
stand at room temperature for 15 min. The volume was
brought up to the mark with dichloromethane and the absor-
bance was measured at 375 nm against a reagent blank simi-
larly prepared without adding LCZ base solution.
Standard graph was prepared by plotting the absorbance
versus drug concentration, and the concentration of the un-
known was read from the calibration graph or computed from
the respective regression equation.
2.5. Procedure for commercial dosage forms
2.5.1. Tablets
Twenty tablets were weighed and pulverized. The amount of
tablet powder equivalent to 35.7 mg of LCZ was transferred
into a 100 mL volumetric ﬂask. The content was shaken well
with about 50 mL of water for 20 min and diluted to the mark
with water. It was ﬁltered using Whatmann No. 42 ﬁlter paper.
First 10 mL portion of the ﬁltrate was discarded. Twenty mil-
liliters of the tablet extract (300 lg mL1) was quantitatively
transferred to a separating funnel, pH was raised by adding
5.0 mL of 1.0 M NaOH and the content was mixed well. Thelevocetirizine base was extracted with three 20 mL portions
of dichloromethane, the extract was passed over anhydrous so-
dium sulphate and collected in 100 mL volumetric ﬂask, the
volume was made up to mark with dichloromethane and the
resulting solution (60 lg mL1 LCZ) was used in method C
and diluted to 30 and 40 lg mL1 LCZ for method A, method
B, respectively, and used for the assay.
2.5.2. Syrup
The content of ﬁve syrup bottles (5 mL lezyncet syrup equiva-
lent to 2.5 mg levocetirizine dihydrochloride) were pooled and
mixed together. Volume of Lezyncet syrup equivalent to
35.7 mg of LCZ was accurately measured and transferred into
a 100 mL volumetric ﬂask. The content was shaken well with
about 50 mL of water for 20 min and diluted to the mark with
water. It was ﬁltered using Whatmann No. 42 ﬁlter paper.
First 10 mL portion of the ﬁltrate was discarded. Transferred
accurately 20 mL of the syrup extract (300 lg/mL) into a
125 mL separating funnel and levocetirizine base was prepared
as described earlier and used for the assay.
2.5.3. Procedure for the analysis of placebo blank and synthetic
mixture
A placebo blank containing starch (40 mg), acacia (35 mg), so-
dium citrate (35 mg), hydroxyl cellulose (35 mg), magnesium
stearate (35 mg), talc (40 mg) and sodium alginate (35 mg) was
prepared by mixing all the components into a homogeneous
mixture. A 10 mg of the placebo blank was accurately weighed
and its solution was prepared as described under ‘tablets’, and
then subjected to analysis by following the general procedures.
An accurately weighed quantity of LCZ was added to
200 mg of placebo blank and homogenized. An amount of syn-
thetic mixture equivalent containing 10.0 mg LCZ was accu-
rately weighed and transferred into a 50 mL volumetric ﬂask
and the extract equivalent to 100 lg mL1 LCZ was prepared
as described under the general procedure for pure drug and
further diluted to the required concentration and used for
the assay in all the three methods.3. Results and discussion
3.1. Absorption spectra
The reaction of levocetirizine base (LCZ) as n-electron donor)
and the p-acceptors such as DNP and PA, and r-acceptor, I2
result in the formation of C-T complexes. The absorption spec-
tra of LCZ-DNP and LCZ-PA C-T complex resulted in the
formation of intense yellow products which exhibit absorption
maxima at 420 nm (Fig. 2a and b). Similarly, the reaction of
LCZ with I2 results in the formation of a yellow product which
exhibits an absorption maximum 375 nm (Fig. 2c).
3.2. Reaction scheme
Charge-transfer complex is a complex formed between an elec-
tron-donor and an electron-acceptor, characterized by elec-
tronic transition(s) to an excited state in which there is a
partial transfer of electronic charge from the donor to the
acceptor moiety. As a result, the excitation energy of this res-
onance occurs very frequently in the visible region of the
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Figure 2 Absorption spectra (a) LCZ-DNP (b) LCZ-PA (c) LCZ-I2.
36 M.S. Raghu, K. Basavaiahelectro-magnetic spectrum (Foster, 1969). This produces the
usually intense color characteristic of these complexes.
Therefore, LCZ, a nitrogenous base is an n-donor, was made
to react with dinitrophenol, picric acid (p-acceptors) and
iodine (r-acceptor) to produce a colored charge transfer com-
plex in dichloromethane.
3.3. Reaction with p-acceptors
3.3.1. Dinitrophenol (method A) and picric acid (method B)
Trinitrophenol (picric acid) and dinitrophenol react with elec-
tron donor molecule to form charge transfer and proton trans-
fer complexes (Sadeghi and Shamsipur, 1998; Mahrous, 1992;
Issa and Amin, 1993; Xuan et al., 1998). It was used for the
determination of some amine derivatives through the forma-
tion of intense yellow colored complex. Interestingly, theapplication of picric acid for the quantitative estimation of
orphendrine citrate and phentolamine mesylate injections is
ofﬁcial in the USP (United State Pharmaco, 2002).
When an amine is combined with a polynitrophenol, one
type of force ﬁeld produces an acid–base interaction, and the
other, an electron donor–acceptor interaction. The former
interaction leads to the formation of true phenolate by pro-
ton-transfer, and the latter, to a true molecular compound
by charge-transfer (El-Yazbi et al., 2003). Based on this, the
mechanism for method A and method B can be discussed in
terms of transfer of electronic charge from the benzene ring
of LCZ, an electron-rich molecule (a Lewis-base donor), to
the ring of DNP or PA, an electron-deﬁcient molecule (a Le-
wis-acid acceptor), and at the same time the proton of the
hydroxyl group of DNP or PA will transfer to the tertiary
amine of LCZ. The explanation for the produced color in
D I2 I
+
D I DI
+
I
I2 I3+ [ ]
-
+
+
  Outer 
complex
  Inner
complex
Tri-iodide
  ion-pair
Scheme 2 Reaction pathway for the formation of electron donor–
acceptor complex and radical ion between LCZ and iodine.
Optimized and validated spectrophotometric methods 37method A and method B lies in the formation of complexes
between the pairs of molecules LCZ-DNP and LCZ-PA, and
this complex formation leads to the production of two new
molecular orbitals and, consequently, to a new electronic tran-
sition (Regulska et al., 2002).
Because LCZ has two tertiary amino groups in their molec-
ular structure with the availability of non-bonding electron do-
nors, it reacts with dinitrophenol and picric acid in
dichloromethane to yield a yellow coloredC-T complex peaking
at 420 nm (Fig 2a and b). The interaction between LCZ (D), an
n-donor and nitrophenols (A), p-acceptors, is a charge transfer
complexation reaction followed by the formation of radical ions
(Douglas and Donald, 1971) according to the Scheme 1.
D þA! ½D ! A ! Dþ þA
½DonorþAcceptor! Complex! Radical ions3.3.2. Reaction with r-acceptor (iodine) (method C)
LCZ, an n-donor (D), in dichloromethane forms a lemon yel-
low colored C-T complex with iodine (I2) (r-acceptor) and the
resulting colored species was found to absorb maximally at
375 nm (Fig 2c). The color of iodine in dichloromethane is vio-
let showing absorption maximum (kmax) at 500 nm. This color
was changed into lemon yellow when mixed with drug. This
change in color and the appearance of the peak were attributed
to the formation of charge-transfer complex between LCZ and
iodine. The interaction between the donor and acceptor occurs
according to the Scheme 2.
3.4. Optimization of experimental variables
Many experimental variables which were found to affect the
color intensity and stability of the resulting complexes wereOH
R1
R2
R3
DNP or PA
For DNP: R1=R2= NO2 and R3=H
For PA: R1=R2=R3= NO2
Cl
N
N
O
O
OH
Scheme 1 Reaction pathway for the formation of electron donor–acoptimized to achieve maximum sensitivity and adherence to
Beer’s law.
3.4.1. Effect of reagent concentration
The optimum concentration of the reagent required to achieve
maximum sensitivity of the developed color species in each
method was ascertained by adding different amounts of the re-
agent DNP, PA or I2 to a ﬁxed concentration of LCZ. The re-
sults showed that 1.0 mL each of 0.1% DNP 0.05% PA and
0.5% I2 solution was optimum for the production of maximum
and reproducible color intensity (Fig. 3).
3.4.2. Effect of solvent
In order to select a suitable solvent for preparation of the re-
agent solutions used in the study, the reagents were prepared
separately in different solvents such as 1,4-dioxane, chloroform,
acetonitrile, acetone, t-butanol,2-propanol and dichlorometh-
ane. The reaction of LCZ with DNP, PA or I2 was followed;
dichloromethane was best suited for the preparation of DNP,
PA and I2 solution. Similarly, the effect of the diluting solvent
was studied for all the methods and the results showed that
the ideal diluting solvent to achieve maximum sensitivity and
stability of the colored species was dichloromethane in all the
three methods.OH
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Figure 3 Effect of reagent concentration on the formation of
(LCZ–DNP complex, 12 lg mL1 LCZ), (LCZ_PA complex,
16 lg mL1 LCZ) and (LCZ–I2 complex, 24 lg mL
1 LCZ).
38 M.S. Raghu, K. Basavaiah3.4.3. Effect of reaction time and stability of the C-T complexes
The optimum reaction times were determined by measuring
the absorbance of thze complex formed upon the addition of
reagent solution to LCT solution at room temperature. The
reaction of LCZ with DNP in method A and PA in method
B was instantaneous while complete color development was at-
tained after 15 min with I2. The absorbance of the resulting C-
T complexes remained stable for at least more than 20 h for
method A and method B and at least for 45 min in method C.
3.5. Composition of the C-T complexes
The composition of the C-T complex was established by Job’s
method of continuous variations (Harikrishna et al., 2008)
using equimolar concentrations of the drug (base form) and re-
agents (4.48 · 104 M in method A, 2.16 · 104 M in method
B and 4.26 · 104 M). The results indicated that 1:1 (drug/re-
agent) complex is formed in all the methods. Five solutions
containing LCZ and the reagent (DNP, PA or I2) in various0.0 0.2 0.4 0.6 0.8 1.0
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Figure 4 Job’s continuous-variations plots (I) LCZ + DNP (II)
LCZ + PA and (III) LCZ+I2.molar ratios, with a total volume of 5 mL in all the methods
were prepared. The absorbance of solutions was subsequently
measured at 420 nm in method A and method B and 375 nm in
method C. The graphs of the results obtained (Fig. 4) gave a
maximum at a molar ratio of Xmax = 0.5 in all the methods
which indicated the formation of a 1:1 C-T complex between
LCZ and reagent (DNP, PA or I2). Since the steric hindrance
to nitrogen attached to tertiary carbon only the nitrogen
attached to secondary carbon is vulnerable for ion pair.4. Method validation
The proposed methods were validated for linearity, sensitivity,
selectivity, accuracy, precision, robustness, ruggedness and
recovery according to the current ICH guidelines (ICH guide-
lines, 2005).
4.1. Linearity and sensitivity
Under the optimum conditions a linear relation was obtained
between absorbance and concentration of LCT in the ranges
given in Table 1. The calibration graph in each instance is de-
scribed by the equation:
Y ¼ aþ bX
(where Y= absorbance, a= intercept, b= slope and
X= concentration in lg mL1). LOD and LOQ were calcu-
lated according to the current ICH guidelines and compiled
in Table 1.
4.2. Accuracy and precision
In order to determine the accuracy and precision of the pro-
posed methods, pure drug (LCT) solution at three different
concentration levels (within the working range) were prepared
and analyzed during the same day (intra-day precision) and on
ﬁve consecutive days (inter-day precision) and the results are
presented in Table 2.
4.3. Selectivity
The selectivity of the proposed methods for the analysis of
LCT was evaluated by placebo blank and synthetic mixture
analyses. The recommended procedures were applied to the
analysis of placebo blank and the resulting absorbance read-
ings in all the methods were same as that of the reagent blank,
conﬁrming no interference from the placebo. The analysis of
synthetic mixture solution prepared as described earlier yielded
percent recoveries of 98.3 ± 2.13, 99.1 ± 1.76 and 98.9 ± 1.91
(n= 5) for method A, method B and method C, respectively.
The results of this study showed that the inactive ingredients
did not interfere in the assay indicating the high selectivity of
the proposed methods and its utility for routine determination
in pure drug and in tablets form.
4.4. Application to analysis of tablets/syrup containing LCT
The proposed methods were successfully applied to the deter-
mination of LCT in two brands of tablets and syrup and the re-
sults are compiled in Table 3. The results obtained were
Table 1 Sensitivity and regression parameters.
Parameter Method A Method B Method C
kmax (nm) 420 420 375
Color stability 20 h 20 h 45 min
Linear range (lg mL1) 1.2–24 1.6–32 2.4–48
Molar absorptivity (e) (L mol1 cm1) 1.6 · 104 1.4 · 104 1.0 · 104
Sandell sensitivitya (lg cm2) 0.0284 0.0323 0.0458
Limit of detection (LOD) (lg mL1) 0.20 0.39 0.51
Limit of quantiﬁcation (LOQ) (lg mL1) 0.61 1.17 1.53
Regression equation, Yb
Intercept (a) 0.0046 0.0088 0.0033
Slope (b) 0.0364 0.0320 0.223
Regression coeﬃcient (r) 0.9999 0.9999 0.0078
a Limit of determination as weight in lg per mL of solution, which corresponds to an absorbance of A= 0.001 measured in a cuvette of cross-
sectional area 1 cm2 and l = 1 cm.
b Y = a+ bX, where Y is the absorbance, X is concentration in lg/mL.
Table 2 Evaluation of intra-day and inter-day accuracy and precision.
Method LCZ taken lg mL1 Intra-day accuracy and precision (n= 5) Inter-day accuracy and precision (n= 5)
LCZ found lg mL1 %RE %RSD LCZ found lg mL1 %RE %RSD
A 6.0 6.12 2.14 1.13 6.24 2.38 1.34
12.0 12.20 1.70 1.90 12.45 2.06 2.53
18.0 18.25 1.39 2.11 18.48 1.72 2.23
B 8.0 7.84 1.88 1.56 8.08 1.90 2.12
16.0 16.33 2.06 1.20 16.52 1.95 2.45
24.0 24.81 1.73 1.66 24.94 2.12 2.08
C 12.0 12.11 0.95 1.99 12.24 1.32 2.46
24.0 23.57 1.76 1.22 24.19 2.06 1.84
32.0 32.61 1.91 1.38 32.92 2.34 1.73
RE – relative error and RSD – relative standard deviation.
Table 3 Results of analysis of tablets/syrup by the proposed methods.
Tablet/syrup brand namec Label claima Foundb (percent of label claim ± SD)
Reference method Proposed methods
A B C
Allercet 5 100.3 ± 0.64 98.61 ± 1.19 101.92 ± 1.37 99.17 ± 1.08
t= 2.66 t= 2.30 t= 1.90
F= 2.38 F= 3.16 F= 1.96
Xyzal 5 99.38 ± 0.56 101.20 ± 1.37 98.61 ± 1.28 102.16 ± 1.16
t= 2.74 t= 1.08 t= 2.39
F= 5.98 F= 5.22 F= 4.29
Lezyncet 2.5 97.28 ± 0.72 98.06 ± 1.37 98.61 ± 1.28 97.96 ± 1.16
t= 1.12 t= 2.02 t= 1.11
F= 3.62 F= 3.16 F= 2.59
Xyzal-UCB India Pvt. Ltd., and Lezyncet syrup – Mepro pharmaceuticals Pvt. Ltd. The value of t and F (tabulated) at 95% conﬁdence level and
for four degrees of freedom are 2.77 and 6.39, respectively.
a mg/tablet in tablets and mg/5 mL in syrup.
b Mean value of ﬁve determinations.
c Allercet – Micro labs Ltd.
Optimized and validated spectrophotometric methods 39statistically compared with those obtained by the reference
method (Indian Pharmacopoeia, 2007), by applying the Stu-
dent’s t-test for accuracy and F-test for precision at 95% conﬁ-
dence level. The reference method involves acid–base titration
to the potentiometric end point in acetone/water system. Ascan be seen from the Table 3, the calculated t- and F-values
at 95% conﬁdence level did not exceed the tabulated values
for four degrees of freedom. This indicates that there are no
signiﬁcant differences between the proposed methods and the
reference method with respect to accuracy and precision.
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The accuracy and validity of the proposed methods were fur-
ther ascertained by performing recovery studies. Pre-analyzed
tablet powder was spiked with pure LCT at three concentra-
tion levels (50%, 100% and 150% of that in tablet powder)
and the total was analyzed by the proposed methods. The re-
sults of this study are presented in Table 4 and indicate that
the excipients present in the tablets did not interfere in the
assay.
5. Conclusion
Three simple, sensitive, extraction-free, rapid and cost-effective
spectrophotometric methods based on charge transfer complex
formation reaction are described for the determination of
LCT. The methods were developed and validated as per the
current ICH guidelines. The proposed methods utilize a single
step reaction and a single solvent. No substantial differences
among the proposed methods arose from analysis of the exper-
imental results. The methods are free from interferences from
the common excipients and additives. The statistical parame-
ters and the recovery data reveal good accuracy and precision
of the methods. These methods can be used as general methods
for the determination of LCT in bulk powder, tablets and syr-
up, have many advantages over the separation techniques such
as HPLC, are of reduced cost, and speed with high accuracy.
Hence, these methods can be used in routine analysis of drug
in quality control laboratories.Acknowledgements
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